Long-term results from a randomized controlled trial to increase cancer screening among attendees of Community Health Centers

Annals of Family Medicine

Volumn 3, Issue 2, 2005, Pages 109-114

  Roetzheim, Richard G ^a,b   Christman, Lisa K ^a   Jacobsen, Paul B ^b   Schroeder, Jennifer ^a   Abdulla, Rania ^a   Hunter, Seft ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast neoplasms; Colorectal neoplasms; Community health centers; Mammography; Mass screening; Occult biood; Primary health care; Vaginal smears

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEALTH CENTER; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; OCCULT BLOOD; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAMPLING; TREATMENT OUTCOME;

AGED; COMMUNITY HEALTH CENTERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 16444382662     PISSN: 15441709     EISSN: None     Source Type: Journal    
DOI: 10.1370/afm.240     Document Type: Article

References (51)

1. Miller B, Ries L, Hankey B, Kosary C, Edwards B. Cancer Statistics Review: 1973-1989. Washington, DC: National Cancer Institute; 1992;9. NIH Publication 92-278.
2. Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health. 1996;86:1794-1797.
3. Ndubuisi SC, Kofie VY, Andoh JY, Schwartz EM. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology. 1995;46:71-77.
4. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999;91:1409-1415.
5. Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000;90:1746-1754.
6. Roetzheim RG, Gonzalez EC, Ferrante JM, Pal N, Van Durme DJ, Krischer JP. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer. 2000;89:2202-2213.
7. Richardson JL, Langholz B, Bernstein L, Burciaga C, Danley K, Ross RK. Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer. 1992;65:922-926.
8. Farley TA, Flannery JT. Late-stage diagnosis of breast cancer in women of lower socioeconomic status: public health implications. Am J Public Health. 1989;79:1508-1512.
9. Wells BL, Horm JW. Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health. 1992;82:1383-1385.
10. Bassett M, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health. 1986;76:1400-1403.
11. Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health. 1991;81:646-649.
12. Hunter C, Redmond C, Chen V, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. J Natl Cancer Inst. 1993;85:1129-1137.
13. Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer. Survival Study. JAMA. 1994;272:947-954.
14. Ayanian J, Kohler B, Abe T, Epstein A. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329:326-331.
15. Stein J, Fox S. Language preference as an indicator of mammography use among Hispanic women. J Natl Cancer Inst. 1990;82:1715-1716.
16. Calle E, Flanders W, Thun M, Martin L. Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health. 1993;83:53-60.
17. Anderson L, May D. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85:840-842.
18. Lee J, Vogel V. Who uses screening mammography regularly? Cancer Epidemiol Biomarkers Prev. 1995;4:901-906.
19. Harlan L, Bernstein A, Kessler L. Cervical cancer screening: who is not screened and why? Am J Public Health. 1991;81:885-891.
20. Burns R, McCarthy E, Freund K, et al. Black women receive less mammography even with similar primary care. Ann Intern Med. 1996;125:173-182.
21. National Cancer Institute Breast Cancer Screening Consortium. Screening mammography: a missed clinical opportunity? JAMA. 1990;264:54-58.
22. Anonymous. Breast and cervical cancer screening among underserved women. Baseline survey results from six states. The National Cancer Institute Screening Consortium for Underserved Women. Arch Fam Med. 1995;4:617-624.
23. Hayward R, Shapiro M, Freeman H, Corey C. Who gets screened for cervical and breast cancer? Results from a new national survey. Arch Intern Med. 1988;1177-1181.
24. Breen N, Kessler L. Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys. Am J Public Health. 1994;84:62-67.
25. Dietrich A, O'Connor G, Keller A. Cancer: improving early detection and prevention. Br Med J. 1992;304:687-691.
26. Manfredi C, Czaja R, Freels S, Trubitt M, Warnecke R, Lacey L. Prescribe for health. Improving cancer screening in physician practices serving low-income and minority populations. Arch Fam Med. 1998;7:329-337.
27. Roetzheim R, Christman L, Jacobsen P, et al. A randomized controlled trial to increase cancer screening among attendees of community health centers. Ann Fam Med. 2004;2:294-300.
28. Ornstein S, Garr D, Jenkins R, Rust P, Arnon A. Computer-generated physician and patient reminders: tools to improve population adherence to selected preventive services. J Fam Pract. 1991;32:82-90.
29. Dickey L, Petitti D. A patient-held minirecord to promote adult preventive care. J Fam Pract. 1992;34:457-463.
30. Dietrich A, Tobin J, Sox C, et al. Cancer early-detection services in community health centers for the underserved: a randomized controlled trial. Arch Fam Med. 1998;7:320-327.
31. Dietrich AJ, Sox CH, Tosteson TD, Woodruff CB. Durability of improved physician early detection of cancer after conclusion of intervention support. Cancer Epidemiol Biomarkers Prev. 1994;3:335-340.
32. Fletcher S, Harris R, Gonzalez J, et al. Increasing mammography utilization: a controlled study. J Natl Cancer Inst. 1993;85:112-120.
33. Charlson M, Pompei P, Ales K, Mackenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
34. Charlson M, Szatrowski T, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251.
35. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
36. Liang K, Zeger S. Regression analysis for correlated data. Ann Rev Public Health. 1993;14:43-68.
37. Margolis PA, Lannon CM, Stuart JM, Fried BJ, Keyes-Elstein L, Moore DE Jr. Practice based education to improve delivery systems for prevention in primary care: randomised trial. Br Med J. 2004;328:388.
38. Stange KC, Goodwin MA, Zyzanski SJ, Dietrich AJ. Sustainability of a practice-individualized preventive service delivery intervention. Am J Prev Med. 2003;25:296-300.
39. Goodson P, Murphy Smith M, Evans A, Meyer B, Gottlieb NH. Maintaining prevention in practice: survival of PPIP in primary care settings. Put Prevention Into Practice. Am J Prev Med. 2001;20:184-189.
40. Kinsinger LS, Harris R, Qaqish B, Strecher V, Kaluzny A. Using an office system intervention to increase breast cancer screening. J Gen intern Med. 1998;13:507-514.
41. Stone EG, Morton SC, Hulscher ME, et al. Interventions that increase use of adult immunization and cancer screening services: a metaanalysis. Ann Intern Med. 2002;136:641-651.
42. Mandelblatt J, Kanelsky P. Effectiveness of interventions to enhance physician screening for breast cancer. J Fam Pract. 1995;40:162-171.
43. Lauver DR, Settersten L, Kane JH, Henriques JB. Tailored messages, external barriers, and women's utilization of professional breast cancer screening over time. Cancer. 2003;97:2724-2735.
44. Valanis B, Whitlock EE, Mullooly J, et al. Screening rarely screened women: time-to-service and 24-month outcomes of tailored interventions. Prev Med. 2003;37:442-450.
45. Zhu K, Hunter S, Bernard LJ, et al. An intervention study on screening for breast cancer among single African-American women aged 65 and older. Prev Med. 2002;34:536-545.
46. Zapka JG, Costanza ME, Harris DR, et al. Impact of a breast cancer screening community intervention. Prev Med. 1993;22:34-53.
47. Allen JD, Stoddard AM, Mays J, Sorensen G. Promoting breast and cervical cancer screening at the workplace: results from the Woman to Woman Study. Am J Public Health. 2001;91:584-590.
48. Kim CS, Kristopaitis RJ, Stone E, Pelter M, Sandhu M, Weingarten SR. Physician education and report cards: do they make the grade? Results from a randomized controlled trial. Am J Med. 1999;107:556-560.
49. Hillman AL, Ripley K, Goldfarb N, Nuamah I, Weiner J, Lusk E. Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care. Am J Public Health. 1998;88:1699-1701.
50. Rimer BK, Conaway M, Lyna P, et al. The impact of tailored interventions on a community health center population. Patient Educ Couns. 1999;37:125-140.
51. Messina CR, Lane DS, Grimson R. Effectiveness of women's telephone counseling and physician education to improve mammography screening among women who underuse mammography. Ann Behav Med. 2002;24:279-289.